Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Converting enzyme

Endothelin. The endothelin (ET) peptide family (50) comprises thiee peptides ET-1 (133), ET-2 (134), and ET-3 (135). ET-1, the most abundant, is a 21-amino acid peptide. A 203-amino acid peptide piecuisoi, piepioET, is cleaved after translation by endopeptidases to form a 38-amino acid proET which is converted to active ET by a putative endothelin-converting enzyme (ECE). ET-3 differs from ET-1 and ET-2 by sis amino acids. [Pg.542]

Fig. 10. Pharmacophores for angiotension-converting enzyme. Distances in nm. (a) The stmcture of a semirigid inhibitor and distances between essential atoms from which one pharmacophore was derived (79). (b) In another pharmacophore, atom 1 is a potential zinc ligand (sulfhydryl or carboxylate oxygen), atom 2 is a neutral hydrogen bond acceptor, atom 3 is an anion (deprotonated sulfur or charged oxygen), atom 4 indicates the direction of a hydrogen bond to atom two, and atom 5 is the central atom of a carboxylate, sulfate, or phosphate of which atom 3 is an oxygen, or atom 5 is an unsaturated carbon when atom 3 is a deprotonated sulfur. The angle 1- -2- -3- -4 is —135 to —180° or 135 to 180°, and 1- -2- -3- -5 is —90 to 90°. Fig. 10. Pharmacophores for angiotension-converting enzyme. Distances in nm. (a) The stmcture of a semirigid inhibitor and distances between essential atoms from which one pharmacophore was derived (79). (b) In another pharmacophore, atom 1 is a potential zinc ligand (sulfhydryl or carboxylate oxygen), atom 2 is a neutral hydrogen bond acceptor, atom 3 is an anion (deprotonated sulfur or charged oxygen), atom 4 indicates the direction of a hydrogen bond to atom two, and atom 5 is the central atom of a carboxylate, sulfate, or phosphate of which atom 3 is an oxygen, or atom 5 is an unsaturated carbon when atom 3 is a deprotonated sulfur. The angle 1- -2- -3- -4 is —135 to —180° or 135 to 180°, and 1- -2- -3- -5 is —90 to 90°.
Folic acid deficiency Hyperthermia Phenylketonuria Rheumatic disease Virilizing tumors Drugs and chemicals Androgenic chemicals Angiotensin-converting enzyme inhibitors Captopril, enalapril Antibiotics... [Pg.314]

FIGURE 15.2 Enzymes regulated by covalent modification are called interconvertible enzymes. The enzymes protein kinase and protein phosphatase, in the example shown here) catalyzing the conversion of the interconvertible enzyme between its two forms are called converter enzymes. In this example, the free enzyme form is catalytically active, whereas the phosphoryl-enzyme form represents an inactive state. The —OH on the interconvertible enzyme represents an —OH group on a specific amino acid side chain in the protein (for example, a particular Ser residue) capable of accepting the phosphoryl group. [Pg.463]

As early as 1938, it was known that glycogen phosphorylase existed in two forms the less active phosphorylase b and the more active phosphorylase a. In 1956, Edwin Krebs and Edmond Eischer reported that a converting enzyme could convert phosphorylase b to phosphorylase a. Three years later, Krebs and Eischer demonstrated that the conversion of phosphorylase b to phosphorylase a involved covalent phosphorylation, as in Eigure 15.17. [Pg.477]

Thiazide diuretics have a venerable history as antihypertensive agents until the advent of the angiotensin-converting enzyme (ACE) inhibitors this class of drugs completely dominated first line therapy for hypertension. The size of thi.s market led until surprisingly recently to the syntheses of new sulfonamides related to the thiazides. Preparation of one of the last of these compounds starts by exhaustive reduction of the Diels-Alder adduct from cyclopentadiene and malei-mide (207). Nitrosation of the product (208), followed by reduction of the nitroso group of 209,... [Pg.50]

As illustrated in Figure A8.3 nitrilases catalyse conversions of nitriles directly into the corresponding carboxylic adds (route A), while other nitrile converting enzymes, die nitrile hydratases, catalyse the conversion of nitriles into amides (route B) which, by the action of amidases usually present in the whole cell preparations, are readily transformed into carboxylic adds (route C). [Pg.279]

Angiotensin converting enzyme (ACE) plays a central role in cardiovascular hemostasis. Its major function is the generation of angiotensin (ANG) II from ANGI and the degradation of bradykinin. Both peptides have profound impact on the cardiovascular system and beyond. ACE inhibitors are used to decrease blood pressure in hypertensive patients, to improve cardiac function, and to reduce work load of the heart in patients with cardiac failure. [Pg.9]


See other pages where Converting enzyme is mentioned: [Pg.665]    [Pg.3]    [Pg.55]    [Pg.55]    [Pg.55]    [Pg.55]    [Pg.202]    [Pg.527]    [Pg.539]    [Pg.451]    [Pg.250]    [Pg.253]    [Pg.297]    [Pg.234]    [Pg.240]    [Pg.445]    [Pg.23]    [Pg.129]    [Pg.132]    [Pg.132]    [Pg.139]    [Pg.212]    [Pg.225]    [Pg.328]    [Pg.349]    [Pg.515]    [Pg.573]    [Pg.463]    [Pg.466]    [Pg.96]    [Pg.128]    [Pg.7]    [Pg.58]    [Pg.128]    [Pg.262]    [Pg.148]    [Pg.174]    [Pg.191]    [Pg.9]   


SEARCH



Aldoxime-converting enzymes

Amino acids converting enzyme

Angioedema angiotensin-converting enzyme inhibitor

Angiotensin I converting enzyme (ACE

Angiotensin I converting enzyme (ACE inhibitors

Angiotensin I-Converting Enzyme Gene

Angiotensin I-converting enzym

Angiotensin I-converting enzyme

Angiotensin I-converting enzyme-inhibitory

Angiotensin I-converting enzyme-inhibitory peptides)

Angiotensin II converting enzyme

Angiotensin converting enzyme

Angiotensin converting enzyme (ACE

Angiotensin converting enzyme NSAIDs

Angiotensin converting enzyme acute interstitial nephritis

Angiotensin converting enzyme angioedema

Angiotensin converting enzyme animal models

Angiotensin converting enzyme antagonists

Angiotensin converting enzyme antiproteinuric effects

Angiotensin converting enzyme captopril

Angiotensin converting enzyme cell culture

Angiotensin converting enzyme clinical relevance

Angiotensin converting enzyme conformational restriction

Angiotensin converting enzyme cough

Angiotensin converting enzyme dual inhibitors

Angiotensin converting enzyme gene

Angiotensin converting enzyme hyperkalemia

Angiotensin converting enzyme inhibitors (ACE

Angiotensin converting enzyme inhibitors actions

Angiotensin converting enzyme inhibitors effects

Angiotensin converting enzyme inhibitors heart failure management

Angiotensin converting enzyme inhibitors hypertensive renal disease

Angiotensin converting enzyme inhibitors prevention

Angiotensin converting enzyme inhibitors specific agents

Angiotensin converting enzyme inhibitors transporters

Angiotensin converting enzyme pregnancy

Angiotensin converting enzyme protein structures

Angiotensin converting enzyme structure

Angiotensin-Converting Enzyme and Neutral Endopeptidase

Angiotensin-converting enzyme (ACE) inhibitors for hypertension

Angiotensin-converting enzyme NSAID interactions

Angiotensin-converting enzyme adverse effects

Angiotensin-converting enzyme blockers

Angiotensin-converting enzyme classification

Angiotensin-converting enzyme clinical effects

Angiotensin-converting enzyme clinical pharmacology

Angiotensin-converting enzyme clinical trials

Angiotensin-converting enzyme design

Angiotensin-converting enzyme diabetic nephropathy

Angiotensin-converting enzyme diuretics

Angiotensin-converting enzyme drug interactions

Angiotensin-converting enzyme dysfunction

Angiotensin-converting enzyme functions

Angiotensin-converting enzyme heart failure

Angiotensin-converting enzyme hemodynamic effects

Angiotensin-converting enzyme hypertension treatment

Angiotensin-converting enzyme inhibitor

Angiotensin-converting enzyme inhibitor development

Angiotensin-converting enzyme inhibitors NSAIDs

Angiotensin-converting enzyme inhibitors adverse effects

Angiotensin-converting enzyme inhibitors adverse interactions

Angiotensin-converting enzyme inhibitors and hypertension

Angiotensin-converting enzyme inhibitors angioedema with

Angiotensin-converting enzyme inhibitors availability

Angiotensin-converting enzyme inhibitors binding

Angiotensin-converting enzyme inhibitors bradykinin

Angiotensin-converting enzyme inhibitors captopril

Angiotensin-converting enzyme inhibitors clearance

Angiotensin-converting enzyme inhibitors concepts

Angiotensin-converting enzyme inhibitors congestive heart failure

Angiotensin-converting enzyme inhibitors contraindications

Angiotensin-converting enzyme inhibitors contributions

Angiotensin-converting enzyme inhibitors coronary heart disease

Angiotensin-converting enzyme inhibitors cough with

Angiotensin-converting enzyme inhibitors diabetic nephropathy treatment

Angiotensin-converting enzyme inhibitors dosing

Angiotensin-converting enzyme inhibitors drug interactions

Angiotensin-converting enzyme inhibitors drug interactions with

Angiotensin-converting enzyme inhibitors drugs implication

Angiotensin-converting enzyme inhibitors enalapril

Angiotensin-converting enzyme inhibitors fosinopril

Angiotensin-converting enzyme inhibitors hyperkalemia with

Angiotensin-converting enzyme inhibitors hypertension treatment

Angiotensin-converting enzyme inhibitors in acute coronary syndromes

Angiotensin-converting enzyme inhibitors in heart failure

Angiotensin-converting enzyme inhibitors in hypertension

Angiotensin-converting enzyme inhibitors intravenous

Angiotensin-converting enzyme inhibitors lisinopril

Angiotensin-converting enzyme inhibitors metabolism

Angiotensin-converting enzyme inhibitors myocardial infarction

Angiotensin-converting enzyme inhibitors nephrotoxicity

Angiotensin-converting enzyme inhibitors patients

Angiotensin-converting enzyme inhibitors pharmacokinetics

Angiotensin-converting enzyme inhibitors ramipril

Angiotensin-converting enzyme inhibitors renal disease treatment

Angiotensin-converting enzyme inhibitors renal insufficiency

Angiotensin-converting enzyme inhibitors side effects

Angiotensin-converting enzyme inhibitory

Angiotensin-converting enzyme inhibitory peptides

Angiotensin-converting enzyme interactions

Angiotensin-converting enzyme lead compound

Angiotensin-converting enzyme pathophysiology

Angiotensin-converting enzyme polymorphisms

Angiotensin-converting enzyme renal impairment

Angiotensin-converting enzyme specific agents

Angiotensin-converting enzyme synthesis

Angiotensin-converting enzyme trials

Angiotensin-converting enzyme with NSAIDs

Angiotensin-converting enzyme with diuretics

Angiotensin-converting enzyme with lithium

Angiotensin-converting-enzyme inhibitor ACEI)

Angiotension converting enzyme

Angiotension-converting enzyme inhibitors

Antihypertensive drugs angiotensin-converting enzyme inhibitors

Benazepril converting enzyme

Capoten Angiotensin converting enzyme inhibitor

Captopril converting enzyme

Captopril converting enzyme) inhibitors

Cardiac failure angiotensin-converting enzyme

Cardiovascular disease angiotensin-converting enzyme

Cardiovascular drugs angiotensin-converting enzyme inhibitors

Congestive heart failure angiotensin-converting enzyme

Converting enzyme inhibitors

Enalapril converting enzyme

Endothelin converting enzyme assay

Endothelin converting enzyme inhibition

Endothelin-converting enzyme

Endothelin-converting enzyme (ECE

Endothelin-converting enzyme inhibitors

Glucose-converting enzymes

Hemodynamically-mediated kidney injury angiotensin-converting enzyme inhibitors

Hypertension angiotensin-converting enzyme

IL-ip converting enzyme

Inhibitors of angiotensin-converting enzyme

Interleukin-1 P-converting enzyme

Interleukin-1 converting enzyme

Interleukin-1/? converting enzyme inhibitors

Interleukin-ip converting enzym

Interleukin-ip-converting enzyme

Kininase angiotensin converting enzyme

Lanosterol converting enzyme

Lisinopril converting enzyme

Lithium angiotensin converting enzyme

Myocardial infarction, treatment angiotensin-converting enzyme

Nitrile Converting Enzymes Involved in Natural and Synthetic Cascade Reactions

Nitrile-Converting Enzymes and their Synthetic Applications

Nitrile-converting enzymes

Nitrile-converting enzymes NHases

Nitrile-converting enzymes aliphatic

Nitrile-converting enzymes aromatic

Nitrile-converting enzymes nitrilases

Nitrile-converting enzymes plant

Pharmacokinetics angiotensin-converting enzyme

Ras converting enzyme

Serum angiotensin-converting enzyme

Stereoselective nitrile converting enzymes

Study Angiotensin-Converting Enzyme Inhibitors

TNF-a converting enzyme

TNF-a converting enzyme TACE)

TNFa converting enzyme

TNFa converting enzyme TACE)

Tumor necrosis factor-a-converting enzyme

Tumour converting enzyme

© 2024 chempedia.info